GYNECOLOGIC CANCERS

Latest News

Pembrolizumab/Lenvatinib Miss OS, PFS in Endometrial Cancer
Pembrolizumab/Lenvatinib Miss OS, PFS in Endometrial Cancer

December 8th 2023

The phase 3 LEAP-001 trial did not meet its primary end points of overall survival and progression-free survival.

Mirvetuximab sBLA Receives FDA Priority Review in Ovarian Cancer
Mirvetuximab sBLA Receives FDA Priority Review in Ovarian Cancer

December 5th 2023

FDA Grants FTD to Olvi-Vec in Ovarian Cancer Subgroup
FDA Grants FTD to Olvi-Vec in Ovarian Cancer Subgroup

November 28th 2023

Novel Treatment Shows Safety/Tolerability in Ovarian Cancer
Novel Treatment Shows Safety/Tolerability in Ovarian Cancer

November 14th 2023

ENB-003 Data Shows Promise in Platinum-Resistant Ovarian Cancer
ENB-003 Data Shows Promise in Platinum-Resistant Ovarian Cancer

November 14th 2023

More News